Literature DB >> 9258625

Direct intrauterine sampling: the IUMC Endometrial Sampler.

L C Tao1.   

Abstract

Endometrial cytology has been studied for more than 25 years, and a variety of cytologic devices have been developed for direct sampling of the endometrium. The quality of endometrial samples procured by various devices is markedly different and greatly affects the diagnostic accuracy. A new endometrial sampling device, the IUMC Endometrial Sampler, was developed at the Indiana University Medical Center and approved by the Food and Drug Administration for general medical use. This device is intended for the early detection of endometrial carcinoma and its precursors. It can be used to monitor the endometrial condition of patients receiving estrogen replacement therapy or tamoxifen. It is also useful for the procurement of uncontaminated endometrial samples for microbiologic studies from patients with suspected endometritis. It has the potential to be used for endometrial dating for patients with infertility disorders. In our clinical trials and sampling tests using hysterectomy specimens, adequate and representative endometrial samples without contamination from endocervix and vagina were consistently obtained by this device. The procedure of endometrial sampling using this device and the preparation techniques for endometrial brushing specimens are discussed and illustrated.

Entities:  

Mesh:

Year:  1997        PMID: 9258625     DOI: 10.1002/(sici)1097-0339(199708)17:2<153::aid-dc13>3.0.co;2-f

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding.

Authors:  Stephanie R DeJong; Jamie N Bakkum-Gamez; Amy C Clayton; Michael R Henry; Gary L Keeney; Jun Zhang; Trynda N Kroneman; Shannon K Laughlin-Tommaso; Lisa J Ahlberg; Ann L VanOosten; Amy L Weaver; Nicolas Wentzensen; Sarah E Kerr
Journal:  Cancer Med       Date:  2021-09-16       Impact factor: 4.711

2.  Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

Authors:  Yuxuan Wang; Lu Li; Christopher Douville; Joshua D Cohen; Ting-Tai Yen; Isaac Kinde; Karin Sundfelt; Susanne K Kjær; Ralph H Hruban; Ie-Ming Shih; Tian-Li Wang; Robert J Kurman; Simeon Springer; Janine Ptak; Maria Popoli; Joy Schaefer; Natalie Silliman; Lisa Dobbyn; Edward J Tanner; Ana Angarita; Maria Lycke; Kirsten Jochumsen; Bahman Afsari; Ludmila Danilova; Douglas A Levine; Kris Jardon; Xing Zeng; Jocelyne Arseneau; Lili Fu; Luis A Diaz; Rachel Karchin; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Amanda N Fader; Lucy Gilbert; Nickolas Papadopoulos
Journal:  Sci Transl Med       Date:  2018-03-21       Impact factor: 17.956

3.  Combining endometrium sampling device and SurePath preparation to screen for endometrial carcinoma: a validation study.

Authors:  Jia Wen; Rui Chen; Jian Zhao; Yin Dong; Xi Yang; Qin-Ping Liao
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

Review 4.  Endometrial sampling devices for early diagnosis of endometrial lesions.

Authors:  Jiang Du; Yaling Li; Shulan Lv; Qing Wang; Chao Sun; Xin Dong; Ming He; Qurat Ulain; Yongxing Yuan; Xiaoqian Tuo; Nasra Batchu; Qing Song; Qiling Li
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-11       Impact factor: 4.553

5.  Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene.

Authors:  Hans Verstraelen; Ramiro Vilchez-Vargas; Fabian Desimpel; Ruy Jauregui; Nele Vankeirsbilck; Steven Weyers; Rita Verhelst; Petra De Sutter; Dietmar H Pieper; Tom Van De Wiele
Journal:  PeerJ       Date:  2016-01-19       Impact factor: 2.984

Review 6.  Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer.

Authors:  Milan Milosav Terzic; Gulzhanat Aimagambetova; Sanja Terzic; Melanie Norton; Gauri Bapayeva; Simone Garzon
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.